scientific programme
37
wednesday, 25 June 2014
PL-05
PLENARY LECTURE
09:00–09:45
Plenary Hall A
Track: Clinical
Topic: Bipolar disorder (A)
Preventive strategies in emerging mental
disorders in young people: Clinical stag-
ing and translational research
Patrick McGorry, Australia
Learning Objectives:
Delegates attending this
presentation will have an update on strategies
for early intervention in those at risk for de-
veloping a psychiatric disorder.
S-21
SYMPOSIUM
10:00–12:00
Ballroom A
Track: Clinical
Topic: Anxiety disorders (A)
Personalized medicine in mood and anxi-
ety disorders
Chair:
Charles Nemeroff, USA
Co-Chair: Alan F. Schatzberg, USA
S-21-001
Neurobiological consequences of child abuse
Charles Nemeroff, USA
S-21-002
Advances in genomics and epigenetic bio-
markers for vulnerability and treatment re-
sponse in mood and anxiety disorders
Elisabeth Binder, Germany
S-21-003
The role of inflammation in the pathophysi-
ology of depression: Treatment implications
Carmine Pariante, United Kingdom
S-21-004
The contribution of HPA axis alterations in
defining subtypes in depression: Genetic,
endocrine and treatment studies
Alan F. Schatzberg, USA
Learning Objectives:
Personalized medicine
is a major goal for the treatment of psychiatric
disorders. Delegates who attend this sympo-
sium will gain and update on progress towards
personalised medicine for mood and anxiety
disorders.
S-22
SYMPOSIUM
10:00–12:00
Ballroom B
Track: Clinical
Topic: Schizophrenia (A)
Is schizophrenia a progressive disease?
Chair:
Robert Zipursky, Canada
Co-Chair: Robin Murray, United Kingdom
S-22-001
Early course of cognitive impairment in
schizophrenia: Effects and influences
Eileen Joyce, United Kingdom
S-22-002
Schizophrenia is not progressive: The clini-
cal evidence
Robin Murray, United Kingdom
S-22-003
Explaining progressive brain changes in
schizophrenia. The role of drugs, stress and
inflammation
Christos Pantelis, Australia
S-22-004
Expecting recovery not progression in
schizophrenia
Robert Zipursky, Canada
Learning Objectives:
This symposium will
review the argument that schizophrenia is a
progressive disease as this may affect the man-
agement of people with that disorder.
S-23
SYMPOSIUM
10:00–12:00
Ballroom C
Track: Translational
Topic: Depression (A)
Psychiatric disorders, 24-hour circadian
rhythms: Clock genes and new treatment
implications
Chair:
William Bunney, USA
Co-Chair: Joseph Takahashi, USA
S-23-001
Clock genes in control and major depres-
sive disorder brain tissue: Possible mode
of action of the rapid-acting antidepressant
low-dose Ketamine
William Bunney, USA
